Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$138,282,402
+$356,499 QoQ
Shares Held
381,869
-2.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#116
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. AMGN ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
This page
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
954,962 | $120,649,899 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,282,402 | 381,869 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $137,925,903 | 392,002 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $113,262,024 | 346,039 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $96,246,285 | 341,057 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $94,555,583 | 338,654 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $101,145,642 | 324,653 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $73,387,622 | 281,567 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $94,318,600 | 292,724 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $86,746,118 | 277,632 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $70,269,688 | 247,150 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $71,955,172 | 249,827 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $62,563,027 | 232,784 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $44,405,776 | 200,008 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $49,647,230 | 205,366 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $52,207,841 | 198,781 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $43,004,066 | 190,790 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,527,195 | 195,344 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $40,600,852 | 167,897 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $33,614,117 | 149,416 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $29,396,310 | 138,238 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $37,806,600 | 155,104 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $38,128,888 | 153,245 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $33,041,573 | 143,709 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,673,583 | 171,835 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $43,610,277 | 184,899 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $68,898,398 | 339,853 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||